Agenus Inc (AGEN)’s Pretax Margin and Net Margin Explained

At the time of writing, Agenus Inc [AGEN] stock is trading at $0.75, up 7.29%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AGEN shares have gain 17.40% over the last week, with a monthly amount glided 5.16%, and seem to be holding up well over a long-time horizon.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

On 31, January 2024, Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference. In a post published today on Yahoo Finance, Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat and investor one-on-ones at the upcoming Oppenheimer Healthcare Conference on February 13th – 14th. The fireside chat will take place at 8:00 a.m. ET on February 14th.

From an analyst’s perspective:

Agenus Inc [NASDAQ: AGEN] stock has seen the most recent analyst activity on June 06, 2023, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $8.

For the past year, the stock price of Agenus Inc fluctuated between $0.53 and $2.41. Agenus Inc [NASDAQ: AGEN] shares were valued at $0.75 at the most recent close of the market.

Analyzing the AGEN fundamentals

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7046 points at the first support level, and at 0.6612 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7832, and for the 2nd resistance point, it is at 0.8184.

Agenus Inc [AGEN] reported earnings per share of -$0.16 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.19/share, meaning a difference of $0.03 and a surprise factor of 15.80%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.2 per share as compared to estimates of -$0.2 per share, a difference of $0 representing a surprise of 0.00%.

Ratios To Look Out For

It is important to note that Agenus Inc [NASDAQ:AGEN] has a current ratio of 0.63.

Transactions by insiders

Recent insider trading involved WIINBERG ULF, Director, that happened on Nov 15 when 25000.0 shares were purchased. 10% Owner, AGENUS INC completed a deal on Oct 16 to buy 429.0 shares. Meanwhile, 10% Owner AGENUS INC bought 19373.0 shares on Oct 13.

Related Posts